← Back to headlines
Amylyx Reports Success in Late-Stage Trial for GLP-1 Drug
Amylyx Pharmaceuticals has announced successful results from a late-stage clinical trial for its GLP-1 drug.
18 Aug, 11:20 — 18 Aug, 11:20
Sources
Showing 1 of 1 sources
Related Stories
Uber Announces Global Layoffs and Exits Nigerian, Ugandan Markets
22m ago
Broadcom Shares Drop Despite Strong Earnings as Weak Guidance Disappoints Investors
30m ago
Snowflake Stock Surges Past 20 Percent on Strong Results and AI Growth Outlook
34m ago
Major Retailers and Automakers Report Mixed August Sales Figures
45m ago